Analysis of Cognitive Levels and Influencing Factors in Children with Obstructive Sleep Apnea
- PMID: 39767857
- PMCID: PMC11674426
- DOI: 10.3390/children11121428
Analysis of Cognitive Levels and Influencing Factors in Children with Obstructive Sleep Apnea
Abstract
Background: Obstructive sleep apnea (OSA) in children is prevalent worldwide and affects their physiological, psychological, and cognitive functions. However, the research on OSA's impact on children's cognitive function remains inconclusive. This study aims to analyze the cognitive levels and influencing factors in children with OSA in a single-center study in China.
Methods: We selected 110 children with OSA who visited the Department of Otorhinolaryngology, Head and Neck Surgery at the Children's Hospital of Zhejiang University School of Medicine from March 2023 to April 2024. Cognitive function was assessed using the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV), and data on the OAHI, BMI, lowest blood oxygen saturation, and tonsillar hypertrophy were collected. A correlation analysis was performed using SPSS Statistics 26.0.
Results: The mean WISC-IV score of the children with OSA was 102.32, within the normal range. Gender and tonsillar grade had no significant effect on the cognitive levels. The BMI scores were significantly negatively correlated with verbal comprehension. The OAHI was weakly negatively correlated with perceptual reasoning but not with other cognitive dimensions.
Conclusions: OSA may negatively affect specific cognitive domains in children, particularly perceptual reasoning and working memory. The BMI is a crucial factor influencing cognitive function in children with OSA. Future research should increase the sample size, include more variables, and conduct long-term follow-ups to comprehensively evaluate the influencing factors of OSA on children's cognitive function.
Keywords: OSA; children; cognitive functioning; influencing factors.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Assessment of event-related evoked potentials and China-Wechsler intelligence scale for cognitive dysfunction in children with obstructive sleep apnea.Int J Pediatr Otorhinolaryngol. 2021 Nov;150:110901. doi: 10.1016/j.ijporl.2021.110901. Epub 2021 Aug 24. Int J Pediatr Otorhinolaryngol. 2021. PMID: 34450546
-
Serum neurofilament light reflects cognitive dysfunctions in children with obstructive sleep apnea.BMC Pediatr. 2022 Jul 26;22(1):449. doi: 10.1186/s12887-022-03514-9. BMC Pediatr. 2022. PMID: 35879699 Free PMC article.
-
[The relationship between birth weight and obstructive sleep apnea in children].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Mar;38(3):230-234. doi: 10.13201/j.issn.2096-7993.2024.03.010. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024. PMID: 38433693 Free PMC article. Chinese.
-
Pediatric Ocular Health and Obstructive Sleep Apnea Syndrome: A Review.Pediatr Rep. 2023 Dec 14;15(4):741-749. doi: 10.3390/pediatric15040066. Pediatr Rep. 2023. PMID: 38133434 Free PMC article. Review.
-
Cognitive deficits in adults with obstructive sleep apnea compared to children and adolescents.J Neural Transm (Vienna). 2017 Feb;124(Suppl 1):187-201. doi: 10.1007/s00702-015-1501-6. Epub 2016 Jan 4. J Neural Transm (Vienna). 2017. PMID: 26729362 Free PMC article. Review.
References
-
- Alkhalifah K.M., Alsalhi S.F., Saleh A., Alrashed S.A.A., Alharbi M.S., Almutairi A.H., Alghanim S.G., Saleh A., Alkharraz A.N.A., Alradhi M.K. Worldwide Prevalence of obstructive sleep apnea among pediatrics: A Systematic Review and Meta-Analysis. Int. J. Med. Dev. Ctries. 2024;8:455–459. doi: 10.24911/IJMDC.51-1701581085. - DOI
-
- Rosen C.L., Larkin E.K., Kirchner H.L., Emancipator J.L., Bivins S.F., Surovec S.A., Martin R.J., Redline S. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: Association with race and prematurity. J. Pediatr. 2003;142:383–389. doi: 10.1067/mpd.2003.28. - DOI - PubMed
-
- Dougados M., Wei J.C., Landewé R., Sieper J., Baraliakos X., Van den Bosch F., Maksymowych W.P., Ermann J., Walsh J.A., Tomita T., et al. Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) Ann. Rheum. Dis. 2020;79:176–185. doi: 10.1136/annrheumdis-2019-216118. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous